Back

Effect of CSFV on Differential Genes of Histone Lactylation at H3K18 in the PI3K-AKT Signaling Pathway

Zhang, H.; Han, Z.; Zhao, X.; Zhu, J.; Shao, N.; Sun, K.; Li, W.; Yao, Y.; Liang, X.; Yang, M.; Gao, Y.; Chen, J.; Liang, Y.; Liu, Q.; Li, X.; Cao, Z.

2026-06-29 microbiology
10.64898/2026.06.26.734696 bioRxiv
Show abstract

Classical swine fever (CSF) is a highly contagious disease caused by Classical swine fever virus (CSFV), posing a serious threat to the global swine industry. This study aimed to investigate the effect of CSFV on differential genes of histone lactylation at the H3K18 site in the PI3K-AKT signaling pathway. The site with the most significant change in histone lactylation antibody level was screened by Western blot. Omics analysis was performed using CUT&Tag technology to identify differential genes in the PI3K-AKT pathway between the CSFV-infected group and the mock group, followed by validation using RT-qPCR. Functional analysis of significantly differential proteins was conducted, and the protein expression level of THBS4 was detected by Western blot. The results showed that after CSFV infection of 3D4/21 cells, the H3K18la site exhibited the most significant difference in antibody level. A total of 8,859 differential genes at the H3K18la site were identified by CUT&Tag analysis, including 6,349 up-regulated genes and 2,510 down-regulated genes. Further focusing on the PI3K-AKT signaling pathway, 10 differential genes were identified, comprising 6 up-regulated genes and 4 down-regulated genes. Compared with the control group, the mRNA expression levels of CD19, LAMA1, PDGFRA, BDNF, ANGPT4, and THBS4 were up-regulated in the CSFV-infected group, while FOXO3 and NRTN were down-regulated. Western blot results showed that the protein expression level of THBS4 increased after CSFV infection. These findings lay an important foundation for understanding the molecular mechanisms regulating viral replication and immune evasion, and have significant scientific implications and potential application value.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 19%
9.6%
2
Journal of Virology
499 papers in training set
Top 1.0%
7.8%
3
Animals
23 papers in training set
Top 0.1%
5.4%
4
Virology Journal
32 papers in training set
Top 0.1%
4.8%
5
Viruses
332 papers in training set
Top 1%
4.0%
6
Frontiers in Microbiology
427 papers in training set
Top 3%
4.0%
7
Scientific Reports
3612 papers in training set
Top 27%
4.0%
8
Emerging Microbes & Infections
74 papers in training set
Top 0.3%
3.2%
9
Journal of Medical Virology
140 papers in training set
Top 0.8%
3.2%
10
Microbial Pathogenesis
17 papers in training set
Top 0.1%
2.6%
11
Transboundary and Emerging Diseases
37 papers in training set
Top 0.2%
2.6%
50% of probability mass above
12
Vaccines
198 papers in training set
Top 1%
2.4%
13
Virology
61 papers in training set
Top 0.6%
2.1%
14
Journal of General Virology
53 papers in training set
Top 0.5%
1.7%
15
Mathematical Biosciences and Engineering
23 papers in training set
Top 0.5%
1.7%
16
Microbiology Spectrum
469 papers in training set
Top 7%
1.5%
17
Archives of Virology
15 papers in training set
Top 0.2%
1.3%
18
mSphere
302 papers in training set
Top 5%
1.3%
19
Journal of Virological Methods
37 papers in training set
Top 0.3%
1.3%
20
Heliyon
152 papers in training set
Top 4%
1.3%
21
Pathogens
56 papers in training set
Top 1%
1.1%
22
PeerJ
308 papers in training set
Top 8%
1.1%
23
PLOS Pathogens
820 papers in training set
Top 8%
1.1%
24
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.8%
1.1%
25
Frontiers in Veterinary Science
32 papers in training set
Top 0.4%
1.1%
26
Virus Research
37 papers in training set
Top 0.6%
1.1%
27
Frontiers in Immunology
638 papers in training set
Top 8%
1.0%
28
Virologica Sinica
11 papers in training set
Top 0.2%
1.0%
29
PLOS Neglected Tropical Diseases
466 papers in training set
Top 5%
1.0%
30
International Journal of Infectious Diseases
129 papers in training set
Top 3%
0.9%